Carley David W. 4
4 · CORTEX PHARMACEUTICALS INC/DE/ · Filed Aug 20, 2012
Insider Transaction Report
Form 4
Carley David W.
Director
Transactions
- Award
Common Stock
2012-08-10+1,899,158→ 1,899,158 total
Footnotes (1)
- [F1]Received in exchange for 525,000 shares of Pier Pharmaceuticals, Inc. common stock, options to purchase 25,000 additional shares of Pier Pharmaceuticals, Inc. common stock and the right to receive $6,000 of cash consideration, all in connection with the merger among Cortex Pharmaceuticals, Inc., Pier Acquisition Corp. (a wholly-owned subsidiary of Cortex Pharmaceuticals, Inc.) and Pier Pharmaceuticals, Inc. (the "Merger"). On the effective date of the Merger, the closing price of the common stock of Cortex Pharmaceuticals, Inc. was $0.06 per share.